News|Articles|February 10, 2023
SCOPE 2023: Future Areas of Investment in Clinical Trials
Author(s)Andy Studna, Senior Editor
Sunny Kumar, MD, partner at GSR Ventures speaks about areas of investment in clinical trials at the SCOPE 2023 conference in Orlando, FL.
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures speaks about how the clinical trials sector is evolving, specifically with increased investment in decentralized trials and recent technological advancements such as artificial intelligence and digital biomarkers.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data
2
ACT Brief: Support Services and Cancer Trial Access, 2025’s Most-Watched ACT Video Interviews, and FDA Approval of Narsoplimab
3
Measuring Barriers to Improve Enrollment and Retention
4
Our Top 5 Most Viewed Video Interviews in 2025
5